Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT06704490
Recruiting Observational

Analysis of the Incidence and Risk Factors of Chronic Pain After Cesarean Section

NCT06704490 · tracked via the Priya Life Science China tracker
Sponsor
Huazhong University of Science and Technology
Phase
Observational
Started
2024-02-01
Last updated
2024-11-26

Condition(s) studied

Postoperative PainCesarean Section Surgery

Investigational drug(s) / intervention(s)

Cesarean section

Cesarean section: Observational study without intervention

Study summary

Persistent postoperative pain is a globally recognized issue that deserves attention. Cesarean section is one of the surgeries that may cause persistent postoperative pain. PSPP may affect communication between mother and baby, and may lead to postpartum depression, which has a negative impact on the daily activities and quality of life of mothers. It is an important clinical issue.

The main purpose of this study is to (1) prospectively investigate the overall incidence and characteristics of persistent pain after cesarean section at 3, 6, and 12 months after surgery; (2) Use regression analysis and data modeling analysis to evaluate the relationship between perioperative variables and chronic pain in postpartum women undergoing cesarean section; (3) Analyze the relationship between chronic pain after cesarean section and postpartum depression in postpartum women.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Age range from 20 to 50 years old; * ASA grades I to III; * Full term pregnancy and planned cesarean section with transverse incision in the lower segment of the uterus; * Pregnant women who are willing to participate in this study and sign informed consent forms. Exclusion Criteria: * Have a history of dementia, mental illness, or any central nervous system disorder; * Pregnant women who are addicted to alcohol and drugs; * Difficulty in follow-up or poor patient compliance; * Has taken other investigational drugs or participated in other clinical trials in the three months prior to being selected for the study; * Serious complications occur during delivery; * Unable to cooperate with the research for any reason.

Primary outcome measure(s)

  • Incidence of chronic pain after caesarean section — 2024-01-01-2025-01-01
    Assessment of chronic postoperative pain by Brief Pain Inventory from 0 to ten, The higher the score, the stronger the pain

Trial sites (1)

FacilityCityRegionStatus
Tongji hospital Wuhan Hubei Recruiting

More Huazhong University of Science and Technology trials in China

The ED95 of Ciprofol for Laryngeal Mask Airway Insertion With Fentanyl in Children: A Biased-Coin Dose-Finding Trial Recruiting
Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes Recruiting
Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection Recruiting
Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions Starting soon
QLESP Block Versus PENG+LFCN Block for Total Hip Arthroplasty Recruiting

Other trials for the same condition

Prospective External Validation of an Early Prediction Model for Adverse Postoperative Pain Trajectories After Orthopedic Surgery Recruiting
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery Recruiting
Perioperative Multimodal Analgesia for Supratentorial Craniotomy Recruiting
Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE） Recruiting
External Oblique Intercostal Block Versus Transversus Abdominis Plane Combined With Rectus Sheath Block on Postoperative Pain in Laparoscopic Radical Gastrectomy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06704490 on ClinicalTrials.gov ↗ ← All trials in China